Patient assessment and differential diagnosis of eyelid and conjunctival lesions

06 Aug 2021
8:00 pm - 8:30 pm

Patient assessment and differential diagnosis of eyelid and conjunctival lesions

Presentation Outline

An overview of eyelid lesions, both benign and malignant that may present to an eye care practitioner. Recognising patterns of various lesions to help make a spot diagnosis.

Learning Objectives

Recognition of common benign lid and conjunctival lesions

Recognition of malignant eyelid and conjunctival lesions

Differentiating between benign and malignant eyelid and conjunctival lesions

Medical and surgical treatment options in eyelid and conjunctival malignant lesions

Therapeutic – Yes

Event Topics

Cornea/Conjunctiva

Oculoplastics (Lids/Lashes/Orbit)

Discussion topics

Red flag signs of periocular skin cancer:

Distorted eyelid anatomy

Loss of the Grey Line

Madarosis/Trichiasis

Secondary ectropion/entropion

Management options in periocular skin cancer

The periocular area is a high risk site and surgical management is the preferred option in the vast majority of cases. A biopsy confirming the diagnosis is often performed prior to reconstructive surgery with margin control. Techniques from simple closure to reconstruction of more extensive defects will be discussed.

Skin cancer statistics and prevention

The most common skin cancer is the basal cell carcinoma (BCC). Over 75% percent of BCCs occur in the head and neck region. At about 20% of BBC appear in periocular region

Within the Periocular region – 50% lower lid, 30% medial canthus, 15% upper lid, 5% lateral canthus.

Approximately 40% of patients who have had one BCC will develop another lesion within five years.